Anticholinergics Stop the Pain and the Motions – A Lesson for Surgeons
Main Article Content
Abstract
Background: Small bowel obstruction commonly presents to surgeons acutely. Adhesions and hernias are the commonest causes. However, medical ileus and gastroparesis are often overlooked.
Case report: This article presents a case of an 82year-old woman on orthopaedic ward referred to the general surgeons with symptoms of small bowel obstruction: bilious vomiting and abdominal distension. Despite all conservative measures, symptoms did not improve. Oral contrast on cross-sectional imaging and gastrograffin follow-through consistently illustrated a transition point at the base of jejunum. No mass or mural lesion was seen. The patient was prescribed regular orphenadrine for cramps over her right periprosthetic femoral fracture. Surgical intervention was then considered on suspicion of adhesional small bowel obstruction. A day before the planned laparotomy, the general surgical team stopped orphenadrine as the last attempt to relieve her symptoms. Ceasing orphenadrine reversed her obstructive symptoms and signs within hours.
Conclusion: Orphenadrine has a broad range of anticholinergic effects that is known to cause gastroparesis and ileus, which is often overlooked. This article discusses the learning points of this case and reviews literature regarding its pharmacologic effects.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. NELA project team. Seventh Patient Report of the National Emergency Laparotomy Audit. Reports - The National Institute of Academic Anaesthesia. https://www.nela.org.uk/reports. November 2021.
3. Rami Reddy SR, Cappell MS. A systematic review of the clinical presentation, diagnosis, and treatment of small bowel obstruction. Current Gastroenterology Reports. 2017; 19(6)1-14.
4. Ten Broek RP, Krielen P, Di Saverio S, Coccolini F, Biffl WL, Ansaloni L, Velmahos GC, Sartelli M, Fraga GP, Kelly MD, Moore FA. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World Journal of Emergency Surgery. 2018; 13(1):1-3.
5. Quah GS, Eslick GD, Cox MR. Laparoscopic versus open surgery for adhesional small bowel obstruction: a systematic review and meta-analysis of case–control studies. Surg Endosc. 2019; 33(10):3209-3217.
6. Batke M, Cappell MS. Adynamic ileus and acute colonic pseudo-obstruction. Medical Clinics of North America. 2008; 92(3):649–70.
7. Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nature Reviews Drug Discovery. 2006; 5(12):993–6.
8. Pubill D, Canudas AM, Pallàs M, Sureda FX, Escubedo E, Camins A, et al. Assessment of the adrenergic effects of orphenadrine in rat vas deferens. Journal of Pharmacy and Pharmacology. 1999; 51(3):307–12.
9. Jaffe T, Thompson WM. Large-bowel obstruction in the adult: Classic radiographic and CT findings, etiology, and mimics. Radiology. 2015; 275(3):651–63.
10. Long B, Robertson J, Koyfman A. Emergency medicine evaluation and management of small bowel obstruction: Evidence-based recommendations. The Journal of Emerg Medicine. 2019; 56(2):166–76.
11. Vather R, Bissett I. Management of prolonged post-operative ileus: Evidence-based recommendations. ANZ Journal of Surgery. 2013; 83(5):319–24.
12. George CF. Drugs causing intestinal obstruction: a review. Journal of the Royal Society of Medicine. 1980; 73(3):200-4.
13. Daggett P, Ibrahim SZ. Intestinal obstruction complicating orphenadrine treatment. BMJ. 1976; 1(6000):21–2.
14. Esang M, Person US, Izekor OO et al. An unlikely case of benztropine misuse in an elderly schizophrenic. Cureus. 2021; 13(2): e13434.
15. Tytgat GN. Hyoscine butylbromide. Drugs. 2007; 67(9):1343–57.